vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
Laird Superfood, Inc.的季度营收约是CAPRICOR THERAPEUTICS, INC.的1.2倍（$13.3M vs $11.1M），Laird Superfood, Inc.净利率更高（-13.2% vs -63.9%，领先50.8%），Laird Superfood, Inc.同比增速更快（15.0% vs -7.9%），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs 16.1%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
CAPR vs LSF — 直观对比
营收规模更大
LSF
是对方的1.2倍
$11.1M
营收增速更快
LSF
高出22.9%
-7.9%
净利率更高
LSF
高出50.8%
-63.9%
两年增速更快
CAPR
近两年复合增速
16.1%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $13.3M |
| 净利润 | $-7.1M | $-1.8M |
| 毛利率 | — | 34.1% |
| 营业利润率 | -69.1% | -13.5% |
| 净利率 | -63.9% | -13.2% |
| 营收同比 | -7.9% | 15.0% |
| 净利润同比 | -833.8% | -341.4% |
| 每股收益（稀释后） | $-0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRLSF
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $12.9M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $11.7M | ||
| Q4 24 | $11.1M | $11.6M | ||
| Q3 24 | $2.3M | $11.8M | ||
| Q2 24 | $4.0M | $10.0M | ||
| Q1 24 | $4.9M | $9.9M |
净利润CAPRLSF
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-975.1K | ||
| Q2 25 | — | $-362.2K | ||
| Q1 25 | — | $-156.2K | ||
| Q4 24 | $-7.1M | $-398.4K | ||
| Q3 24 | $-12.6M | $-166.1K | ||
| Q2 24 | $-11.0M | $-239.1K | ||
| Q1 24 | $-9.8M | $-1.0M |
毛利率CAPRLSF
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
营业利润率CAPRLSF
| Q4 25 | — | -13.5% | ||
| Q3 25 | — | -7.7% | ||
| Q2 25 | — | -3.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | -69.1% | -4.1% | ||
| Q3 24 | -575.2% | -2.3% | ||
| Q2 24 | -291.9% | -3.4% | ||
| Q1 24 | -209.2% | -11.0% |
净利率CAPRLSF
| Q4 25 | — | -13.2% | ||
| Q3 25 | — | -7.6% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | -63.9% | -3.4% | ||
| Q3 24 | -555.2% | -1.4% | ||
| Q2 24 | -277.0% | -2.4% | ||
| Q1 24 | -199.6% | -10.3% |
每股收益（稀释后）CAPRLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.38 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q1 24 | $-0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $11.5M |
| 总资产 | $170.5M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRLSF
| Q4 25 | — | $5.1M | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | $151.5M | $8.3M | ||
| Q3 24 | $85.0M | $7.9M | ||
| Q2 24 | $29.5M | $7.6M | ||
| Q1 24 | $39.9M | $7.1M |
股东权益CAPRLSF
| Q4 25 | — | $11.5M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | — | $13.4M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | $145.5M | $13.2M | ||
| Q3 24 | $68.3M | $13.1M | ||
| Q2 24 | $11.5M | $12.6M | ||
| Q1 24 | $18.4M | $12.7M |
总资产CAPRLSF
| Q4 25 | — | $19.2M | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | — | $20.4M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | $170.5M | $19.3M | ||
| Q3 24 | $93.0M | $18.8M | ||
| Q2 24 | $38.3M | $18.0M | ||
| Q1 24 | $49.4M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $68.4K |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | — |
| 自由现金流率自由现金流/营收 | -137.3% | — |
| 资本支出强度资本支出/营收 | 4.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | — |
8季度趋势，按日历期对齐
经营现金流CAPRLSF
| Q4 25 | — | $68.4K | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $-2.8M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | $-14.8M | $339.2K | ||
| Q3 24 | $-11.6M | $305.8K | ||
| Q2 24 | $-12.3M | $642.7K | ||
| Q1 24 | $-1.3M | $-422.3K |
自由现金流CAPRLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-15.3M | — | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.3M | — | ||
| Q1 24 | $-1.9M | — |
自由现金流率CAPRLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -137.3% | — | ||
| Q3 24 | -515.2% | — | ||
| Q2 24 | -310.9% | — | ||
| Q1 24 | -38.3% | — |
资本支出强度CAPRLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 12.4% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
